depistage-neonatal-de-la-drepanocytose-en-france 2. OMS | Epidémiologie mondiale des troubles de l'hémoglobine et indicateurs de service dérivés, Bulletin épidémiologique hebdomadaire / Publications et outils, 2012. ,
Fetal hemoglobin in sickle cell anemia, Blood, vol.118, issue.1, pp.19-27, 2011. ,
DOI : 10.1182/blood-2011-03-325258
Hydroxyurea in Sickle Cell Disease: Drug Review, Indian Journal of Hematology and Blood Transfusion, vol.101, issue.2, pp.91-97, 2014. ,
DOI : 10.1016/S0027-9684(15)31072-5
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022916/pdf
Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation, Nat Genet. déc, vol.842, issue.12, pp.1049-51, 2010. ,
Les mécanismes de régulation de l'hémoglobine foetale. Hématologie. 1 mai 2010, pp.235-278 ,
DNA sequence variation associated with elevated fetal G gamma globin production, Blood. oct, vol.66, issue.4, pp.783-790, 1985. ,
DNA polymorphisms at the BCL11A, HBS1L-MYB, and ??-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease, Proceedings of the National Academy of Sciences, vol.81, issue.3, pp.11869-74, 2008. ,
DOI : 10.1086/519795
Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation, Nature Genetics, vol.42, issue.12, pp.1049-51, 2010. ,
DOI : 10.1371/journal.pgen.0020132
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740938/pdf
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of ??-thalassemia, Proceedings of the National Academy of Sciences, vol.55, issue.4, pp.1620-1625, 2008. ,
DOI : 10.1111/j.0006-341X.1999.00997.x
BCL11A contrôle l'expression de l'hémoglobine foetale. médecine/sciences. 1 nov 2012, pp.923-928 ,
expression de l'hémoglobine foetale est sous le contrôle du répresseur BCL11A. médecine/sciences, pp.457-60, 2009. ,
Association of Variants at BCL11A and HBS1L-MYB with Hemoglobin F and Hospitalization Rates among Sickle Cell Patients in Cameroon, PLoS ONE, vol.122, issue.6, p.92506, 2014. ,
DOI : 10.1371/journal.pone.0092506.s004
-Thalassemia Intermedia Patients, Hemoglobin, vol.79, issue.6, pp.405-415, 2016. ,
DOI : 10.1002/ajh.22221
URL : https://hal.archives-ouvertes.fr/in2p3-01415342
Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults, Proceedings of the National Academy of Sciences, vol.66, issue.1, pp.11346-51, 2007. ,
DOI : 10.1086/302698
HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers, Journal of Clinical Investigation, vol.124, issue.4, pp.1699-710, 2014. ,
DOI : 10.1172/JCI71520DS1
URL : http://www.jci.org/articles/view/71520/files/pdf
Genetic modifiers of sickle cell disease, American Journal of Hematology, vol.97, issue.8, pp.795-803, 2012. ,
DOI : 10.1007/BF02185763
The alpha-globin genotype does not influence sickle cell disease severity in a retrospective cross-validation study of the pediatric severity score, European Journal of Haematology, vol.339, issue.1, pp.61-68, 2012. ,
DOI : 10.1056/NEJM199807023390102
URL : https://hal.archives-ouvertes.fr/hal-00697964
The Co-Inheritance of Alpha-Thalassemia and Sickle Cell Anemia Is Associated with Better Hematological Indices and Lower Consultations Rate in Cameroonian Patients and Could Improve Their Survival, PLoS ONE, vol.7, issue.6, p.100516, 2014. ,
DOI : 10.1371/journal.pone.0100516.t004
Clinical diversity of sickle cell anemia: Genetic and cellular modulation of disease severity, American Journal of Hematology, vol.306, issue.4, pp.405-421, 1983. ,
DOI : 10.7326/0003-4819-88-1-1
Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes, Blood Reviews, vol.21, issue.1, pp.37-47, 2007. ,
DOI : 10.1016/j.blre.2006.07.001
Genetic Etiologies for Phenotypic Diversity in Sickle Cell Anemia, The Scientific World JOURNAL, vol.9, pp.46-67, 2009. ,
DOI : 10.1100/tsw.2009.10
Genetic predictors for stroke in children with sickle cell anemia, Blood, vol.117, issue.24, pp.6681-6685, 2011. ,
DOI : 10.1182/blood-2011-01-332205
Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes., Journal of Clinical Investigation, vol.73, issue.1, pp.116-139, 1984. ,
DOI : 10.1172/JCI111181
Gilbert syndrome acts as a risk factor of developing gallstone among ? hemoglobinopathy Tunisian patients, Tunis Med. avr, vol.93, issue.4, pp.237-278, 2015. ,
UGT1A1 variation and gallstone formation in sickle cell disease, Blood, vol.105, issue.3, pp.968-72, 2005. ,
DOI : 10.1182/blood-2004-02-0521
URL : http://www.bloodjournal.org/content/bloodjournal/105/3/968.full.pdf
Prevalence and morbidity of G6PD deficiency in sickle cell disease in the homozygote], Dakar Méd, vol.50, issue.2, pp.56-60, 2005. ,
Glucose-6-Phosphate Dehydrogenase Deficiency and Homozygous Sickle Cell Disease in Congo, Human Heredity, vol.48, issue.4, pp.192-199, 1998. ,
DOI : 10.1159/000022801
Glucose-6-Phosphate Dehydrogenase Deficiency and the Sickle Cell Gene in Makkah, Saudi Arabia, Journal of Tropical Pediatrics, vol.40, issue.1, pp.12-18, 1994. ,
DOI : 10.1093/tropej/40.1.12
G6PD deficiency and absence of ??-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia, European Journal of Haematology, vol.163, issue.Suppl 1, pp.404-412, 2016. ,
DOI : 10.1111/bjh.12590
Glucose-6-Phosphate Dehydrogenase Deficiency in Brazilian Children With Sickle Cell Anemia is not Associated With Clinical Ischemic Stroke or High-Risk Transcranial Doppler, Pediatric Blood & Cancer, vol.109, issue.6, pp.1046-1055, 2016. ,
DOI : 10.1590/0074-0276140123
Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study, British Journal of Haematology, vol.88, issue.5, pp.646-54, 2013. ,
DOI : 10.1073/pnas.88.19.8568
10 -Syndromes drépanocytaires majeurs de l'enfant et de l'adolescent. https://www.has-sante.fr/portail/jcms/c_938890/fr/ald-n-10-syndromes- drepanocytaires-majeurs-de-l-enfant-et-de-l-adolescent ,
Newborn screening for sickle cell disease: effect on mortality, Pediatrics. juin, vol.81, issue.6, pp.749-55, 1988. ,
Update on fetal hemoglobin gene regulation in hemoglobinopathies, Current Opinion in Pediatrics, vol.23, issue.1, pp.1-8, 2011. ,
DOI : 10.1097/MOP.0b013e3283420fd0
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092400/pdf
Hydroxyur??e et dr??panocytose??: r??le des prot??ines d???adh??rence, Archives de P??diatrie, vol.16, issue.2, 2009. ,
DOI : 10.1016/j.arcped.2008.11.003
PDF Download Available). https://www.researchgate.net/publication ,
Greffe dans la drépanocytose : résultats, perspectives. Httpwwwem- Premiumcomdocelecu-Bordeauxfrdatarevues0929693X0015000508718578, p.32, 2008. ,
DOI : 10.1016/s0929-693x(08)71857-8
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation, Blood, vol.129, issue.11, pp.1548-56, 2017. ,
DOI : 10.1182/blood-2016-10-745711
Gene Therapy in a Patient with Sickle Cell Disease, New England Journal of Medicine, vol.376, issue.9, pp.848-55, 2017. ,
DOI : 10.1056/NEJMoa1609677
Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells, American Journal of Hematology, vol.74, issue.2, pp.122-152, 1991. ,
DOI : 10.1002/ajh.2830360211
Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions, American Journal of Hematology, vol.37, issue.Pt 3, pp.618-643, 2009. ,
DOI : 10.1042/bj2810627
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209715/pdf
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease, Blood, vol.107, issue.6, pp.2279-85, 2006. ,
DOI : 10.1182/blood-2005-06-2373
Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell Anemia, JAMA, vol.303, issue.18, pp.1823-1854, 2010. ,
DOI : 10.1001/jama.2010.562
Drépanocytose et atteinte vasculaire cérébrale chez l'enfant. Arch Pédiatrie, pp.404-418, 2014. ,
DOI : 10.1016/j.arcped.2014.01.005
Vascular risk assessment in patients with sickle cell disease, Haematologica, vol.96, issue.1, pp.1-5, 2011. ,
DOI : 10.3324/haematol.2010.035097
Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell disease ,
Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island, Hemoglobin, vol.35, issue.5, pp.156-61, 2015. ,
DOI : 10.1002/ajh.23457
Normal splenic size in infants and children: sonographic measurements., American Journal of Roentgenology, vol.157, issue.1, pp.119-140, 1991. ,
DOI : 10.2214/ajr.157.1.2048509
URL : http://www.ajronline.org/doi/pdf/10.2214/ajr.157.1.2048509
Genome Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania, PLoS ONE, vol.5, issue.11, p.111464, 2014. ,
DOI : 10.1371/journal.pone.0111464.t003
Drépanocytose chez l'enfant. Httpwwwem- Premiumcomdocelecu-Bordeauxfrdatatraitespem04-61616 ,
Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre, British Journal of Haematology, vol.26, issue.4, pp.641-648, 2017. ,
DOI : 10.1111/tme.12314
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management, Blood, vol.120, issue.3, pp.528-565, 2012. ,
DOI : 10.1182/blood-2011-11-327361
URL : https://hal.archives-ouvertes.fr/inserm-00696264
Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London, Haematologica, vol.92, issue.7, pp.905-917, 2007. ,
DOI : 10.3324/haematol.10937
Cerebrovascular Accidents in Sickle Cell Disease: Rates and Risk Factors, Blood. 1 janv, vol.91, issue.1, pp.288-94, 1998. ,
Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort, Blood, vol.117, issue.4, pp.1130-1170, 2011. ,
DOI : 10.1182/blood-2010-06-293514
Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study, British Journal of Haematology, vol.120, issue.6, pp.966-77, 2016. ,
DOI : 10.1182/blood-2011-11-327361
Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia, Blood, vol.117, issue.4, pp.1390-1392, 2011. ,
DOI : 10.1182/blood-2010-08-302703
DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil, Blood Cells, Molecules, and Diseases, vol.53, issue.4, pp.176-185, 2014. ,
DOI : 10.1016/j.bcmd.2014.07.006
A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression, Blood, vol.117, issue.18, pp.4935-4980, 2011. ,
DOI : 10.1182/blood-2010-11-317081
Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease, British Journal of Haematology, vol.31, issue.2, pp.274-84, 2016. ,
DOI : 10.1016/j.neuroimage.2006.01.015
Sickle Cell Anemia and Fetal Hemoglobin, The American Journal of the Medical Sciences, vol.308, issue.5, pp.481-486, 2014. ,
DOI : 10.1097/00000441-199411000-00001
Emerging science of hydroxyurea therapy for pediatric sickle cell disease, Pediatric Research, vol.101, issue.1-2, pp.196-204, 2014. ,
DOI : 10.1016/j.bbmt.2012.05.013
The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil, Blood Cells, Molecules, and Diseases, vol.62, pp.32-39, 2016. ,
DOI : 10.1016/j.bcmd.2016.11.002
Genetic Variation on Chromosome 6 Influences F Cell Levels in Healthy Individuals of African Descent and HbF Levels in Sickle Cell Patients, PLoS ONE, vol.10, issue.1, 2621086. ,
DOI : 10.1371/journal.pone.0004218.t002
A genetic score for the prediction of beta-thalassemia severity, Haematologica, vol.100, issue.4, pp.452-459, 2015. ,
DOI : 10.3324/haematol.2014.113886
Homozygous sickle cell disease in Uganda and Jamaica a comparison of Bantu and Benin haplotypes, West Indian Med J. oct, vol.61, issue.7, pp.684-91, 2012. ,
Impact of ??S-Globin Haplotypes on Oxidative Stress in Patients with Sickle Cell Anemia in Steady State, Archives of Medical Research, vol.43, issue.7, pp.536-576, 2012. ,
DOI : 10.1016/j.arcmed.2012.08.014